Osteoporosis is a skeletal condition characterized by decreased density (mass/unit volume) of normally mineralized bone. The reduced density impairs the mechanical strength of the bone, thus making it more vulnerable to fracture.
The World Health Organization has established diagnostic criteria for osteoporosis that are based on bone density measurements determined by dual-energy x-ray absorptiometry (DXA). A patient is classified as having low bone mass if the bone mineral density measures between 1 and 2.5 standard deviations below the mean value in a young reference population. The diagnosis of osteoporosis is made if a patient's bone density is 2.5 standard deviations or more below the mean for young normal people2 (Table 1).
In this definition, it is recognized that there is a strong association between bone mineral density and the likelihood of fracture.4,22,28 According to the criteria, approximately 0.6% of young women have osteoporosis and approximately 16% have low bone mass. By age 75, an estimated 38% of white women will have osteoporosis and 94% will have low bone mass.20,21,25,26 Although the definition is useful for establishing the prevalence of osteoporosis, it is inadequate as a guide to treatment, because other factors influence bone quality and fracture risk. Treatment should be determined for each patient after consideration of these other factors in addition to bone density. Because the risk of osteoporotic fracture during the remaining lifetime of many elderly patients is sufficiently low, aggressive treatment is usually not needed. Conversely, many patients who do not meet the World Health Organization's criteria for osteoporosis might have other risk factors and circumstances that justify treatment. Therefore, the World Health Organization's criteria has made physicians aware of the prevalence of osteoporosis but should not be used to dictate absolute thresholds for diagnosis and treatment.
Osteoporosis has been classified into two categories, primary and secondary. Primary osteoporosis is further divided into three types- postmenopausal osteoporosis (Type I), age-related osteoporosis (Type II), and idiopathic osteoporosis. Postmenopausal (Type I) osteoporosis develops in women who have estrogen deficiency, whereas age-related (Type II) osteoporosis occurs in men and women as their bone density decreases with aging. Secondary osteoporosis refers to those patients in whom a causative factor or disease process is identifiable.18
Osteoporosis is less common in men than in women, probably reflecting that men have greater bone mass than women at all ages, and experience no physiologic equivalent of menopause.24 Nonetheless, severe Type II (age-related) and idiopathic osteoporosis occurs in men. Secondary osteoporosis caused by excessive alcohol in-take, hypogonadism, hypercortisolism, and hyperthyroidism also occur in men and can lead to varying degrees of clinically significant osteoporosis.7,9,12,13,16
Clinical Signs and Symptoms
In osteoporosis, as in hypertension, there is often a long latent period before clinical symptoms or complications develop. The most prevalent sequelae are compression fractures of the vertebral bodies and fractures of the ribs, proximal femurs, humeri, and distal radiuses.
Pathologic fractures are among the most obvious clinical manifestations of osteoporosis.14,17 In patients with osteoporosis, as well as in older persons, fractures are often the result of a fall.11,29 Results reported in recent studies on falls in the elderly have identified numerous predisposing factors. Intrinsic causes include neurologic and musculoskeletal disorders, cardiovascular disorders, and visual disturbances, all common in this population. Extrinsic factors that increase the risk of falls are the use of sedatives, excessive use of prescription medications, dim lighting, cluttered floors, and various other obstructions (scatter rugs, curbs, and stairs).21,23,29-31 Reduced resistance to trauma caused by a decrease in soft tissue padding that can help absorb and deflect the kinetic energy at sites of impact, as well as low bone mass, may contribute to the high incidence of fracture. Hip fractures in thin patients are probably related to decreased resistance and low bone mass. Therefore, persons with ample body fat or well-developed muscles are less likely to sustain a fracture during a fall.14
Vertebral Compression Fractures
The earliest symptom of osteoporosis is often an episode of acute back pain occurring when the person is at rest or during such routine activity as bending, standing from a seated position, lifting a heavy object, or opening a window. Although most compression fractures are painless, pain can occur suddenly. Most patients can recall the exact moment the pain began but may have difficulty identifying the vertebral site involved. Spinal movement is severely restricted, with flexion reduced more than extension. Pain intensifies with sitting or standing and is relieved by bed rest in the fully recumbent position. Coughing, sneezing, and straining to move the bowels can exacerbate the pain. Sitting or standing for prolonged periods may be impossible because of severe pain. The patient walks slowly, but the gait is otherwise normal.
Anterior compression fractures in the thoracic spine may cause thoracic kyphosis (dowager's hump), the stooped posture characteristic of osteoporosis. Loss of vertebral height is usually insidious and painless and is accompanied by loss in height of the intervertebral discs. Involvement of the lumbar spine may lead to progressive loss of the normal lumbar lordosis. Axial height decreases after each fracture, and there is a discrepancy between the standing height and arm span. Patients with severe, progressive spinal compression may have an acquired short trunk and short stature. This is easily identified with the patient in the standing position. Normally the finger tips should come to the mid thigh. In advanced osteoporosis, with loss of axial height, the finger tips come to the lower thigh or knee when the patient is standing. Once the spine has collapsed to the point at which the lower ribs rest on the iliac crest, height remains stable, although bone density may continue to diminish.
After acute vertebral fractures, spasms of the paravertebral muscles are palpable and often visible. The spine and paravertebral muscles may be tender to deep palpation and to percussion at the level of the fracture.
Acute fractures are usually not associated with abnormal neurologic findings, in that they are usually stable injuries. When present, radiculopathy, can cause unilateral or bilateral pain that radiates along the costal margin of the affected spinal nerve. Involvement of the spinal cord or cauda equina is extremely uncommon, and should suggest other conditions, including infection, metastatic or primary bone tumors, myeloma, Paget's disease, or lymphoma.
During intervals between compression fractures, most patients remain pain free. However, some patients continue to be plagued by dull, aching back pain, especially with prolonged standing. This pain can often be relieved with intermittent bed rest throughout the day.
It is important to distinguish chronic back pain from the incapacitating pain of temporally clustered fractures. For a significant number of patients with cluster fractures, the severe pain initiated by the first vertebral compression fracture barely subsides before the occurrence of equally severe pain with the next fracture. Typically, these patients will have multiple fractures in a period of months, followed by gradual recovery. Such patients are able to recall each exacerbation and tend to have more severe pain of longer duration than those with isolated compression fractures. When cluster fractures are suspected in a patient, evaluation for secondary causes of osteopenia is warranted. Exacerbation of a preexisting chronic illness in a severely osteopenic, steroid-dependent patient, or an increase in the glucocorticoid medication often precipitates temporal clustering of fractures.15
Some permanent side effects of progressive vertebral compression fractures are related to decreases in the size of the thoracic and abdominal cavities. Postural changes diminish exercise tolerance. After ingesting even small amounts of food, the patient often feels full and bloated. Severe vertebral collapse in the lumbar spine causes the abdomen to protrude. Circumferential pachydermal skin folds may develop at the rib and pelvic margins as the spinal deformity progresses.
In some persons, osteoporosis is first manifested by a pathologic fracture of the proximal femur or distal radius, sustained after a fall. The incidence of fractures of the femoral neck increase with age.19 Fractures of the proximal femur are among the most feared complications of osteoporosis and are solely responsible for catapulting the disease into the category of a life-threatening disorder. These fractures often occur in patients with several preexisting comorbidities that contribute to more complicated postoperative recovery, including pneumonia, deep vein thrombosis, and fat embolus syndrome. Although reduced bone density is a critical component leading to a fractured hip, other intrinsic and extrinsic factors-cardiac disease, neurologic disorders, and medications that cause dizziness-may be equally important.
Patients typically complain of hip pain and the hip's inability to bear weight. Physical examination reveals a shortened, externally rotated leg. In cases of occult fractures, the patient complains of severe pain when the hip is in a weight-bearing position. Occult hip fractures can be observed in patients who have risk factors for osteoporosis and tend to be more active. Magnetic resonance imaging or a bone scan is often useful in diagnosing occult fractures.
The diagnostic work-up of osteoporosis focuses on evaluating the cause and magnitude of bone loss and on excluding secondary causes of bone loss. In many patients, the diagnosis of osteoporosis is made only after a pathologic fracture has occurred. To avoid the potentially devastating effects of osteoporosis, it may be clinically warranted and cost-effective to assess bone density in patients at high risk before fractures or deformities occur. These low-cost, usually available techniques are valuable diagnostic tools. Serial bone density measurements are extremely useful for monitoring the effectiveness of therapy or preventive interventions.
History and Laboratory Studies
Postmenopausal osteoporosis in women and age-related osteoporosis in men and women are the most common forms of symptomatic bone loss seen in clinical practice. A detailed history, however, may suggest that the low bone density is secondary to hyperthyroidism, primary hyperparathyroidism, hypercortisolism, myeloma, or osteomalacia (Tables 2 and 3).
Risk factors for low bone density have limited value in estimating a person's actual bone density.27 However, determining risk factors for fracture can be useful in identifying those at high risk, and treatment can be initiated to reduce the risk.6 In women, several common, important, and clinically useful risk factors have been identified recently in the Study of Osteoporotic Fractures. These include low bone mineral density; history of a fracture after age 40; history of a fracture of the hip, wrist, or vertebra in a first-degree relative; or current cigarette smoking.5
Obtaining a thorough history facilitates selection of appropriate baseline tests. Routine laboratory tests include complete blood count with leukocyte differential measurement; a 24-hour urine collection to measure calcium and creatinine excretion; and determination of serum levels of calcium, albumin, phosphorus, alkaline phosphatase, blood urea nitrogen, and creatinine (Table 2). In asymptomatic postmenopausal osteoporosis, results of routine laboratory tests are normal and do not assess the extent or rate of bone loss or indicate the prognosis. Even in severe postmenopausal osteoporosis, the serum levels of calcium, inorganic phosphorus, and alkaline phosphatase are usually normal, although alkaline phosphatase levels may rise transiently for several weeks after a fracture. Measurement of biochemical markers appears helpful in assessing bone turnover and aids in monitoring therapy. Total alkaline phosphatase, osteocalcin, Type I collagen propeptides, urinary collagen cross-links, and collagen telopeptides are several markers that may be useful. A complete description of these tests is summarized by Erye in this issue.1,3,8,10
Additional tests are warranted if bone loss caused by conditions other than aging and menopause is suspected. Diagnosis of primary or iatrogenic hyperthyroidism requires measurement of serum triiodothyronine resin uptake (T3RU), and thyroxine (T4) levels, and calculation of the free thyroxine index (FTI). Serum thyroid-stimulating hormone (TSH) levels are markedly suppressed in all forms of hyperparathyroidism and are a sensitive indicator of thyroid status. Serum protein electrophoresis, urinary immunoelectrophoresis and bone marrow aspirate may be needed to detect multiple myeloma. In patients who have hypercalcemia, parathyroid hormone levels must be determined. The serum level of 25-hydroxyvitamin D, an excellent indicator of total body reserves of vitamin D, may be measured to evaluate a possible vitamin D deficiency, the most common biochemical abnormality associated with hip fractures. All men with osteopenia or osteoporosis should have an evaluation of serum testosterone level, in that asymptomatic hypogonadism is a common cause of osteopenia in men.
Osteoporosis and osteomalacia are commonly confused osteopenic conditions in adults. Whereas osteoporosis is characterized by a decreased density of normally mineralized bone matrix, osteomalacia is a qualitative rather than a quantitative disorder of bone metabolism. In osteomalacia, bone density may be increased, normal, or (most commonly) decreased, and bone matrix is insufficiently mineralized.
Unlike its more easily recognized childhood counterpart, rickets, adult osteomalacia may be difficult to diagnose clinically. The incidence is evenly distributed throughout all age groups. The most common causes are chronic renal failure, malabsorption, vitamin D deficiency, abnormalities of the vitamin D pathway, and hypophosphatemic syndromes. Rarer causes are renal tubular acidosis, aluminum intoxication, and hypophosphatasia.
In contrast to osteoporosis, which does not become evident until fractures occur, osteomalacia may cause generalized bone pain, tenderness, and generalized myopathy. Osteomalacia caused by vitamin D deficiency is suggested by bone pain or pathologic fracture in a patient taking anticonvulsants, by a history of malabsorption syndrome in a patient, or by a femoral neck fracture in an older patient. The levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D must be determined when osteomalacia is suspected. The diagnosis can be confirmed with fluorescent microscopic examination of nondecalcified trabecular bone tissue obtained by transiliac bone biopsy after administration of time-separated double tetracycline labeling.
Although the radiographic features of osteoporosis and osteomalacia may be similar, axial changes predominate in osteoporosis, whereas appendicular changes predominate in osteomalacia. Osteomalacia is suggested by symmetric pathologic fractures and traumatic fractures. Pseudofractures (Looser zones) are characteristic of osteomalacia. These small, incomplete cortical fractures develop perpendicular to the long axis of a bone and are often bilaterally symmetric. Common areas of involvement include medial borders of the scapulas, ribs, ischiopubic rami, femoral necks, lateral borders of the femur, and distal radiuses.
Results of routine laboratory studies, typically normal in osteoporosis, may be abnormal in osteomalacia. Osteomalacia should be suspected when the product of the serum calcium level and serum phosphate level is chronically below 25 (with normal serum albumin), especially if accompanied by an elevated bone-specific alkaline phosphatase level and a urinary calcium excretion of less than 50 mg per 24 hours.
The effectiveness of current treatment methods for osteoporosis relies on the accurate diagnosis and classification of the disease process that results in low bone density and fractures. A careful diagnosis that is based on clinical history, physical examination laboratory evaluation, bone densitometry, and radiographic imaging will allow the clinician to enact preventive measures and medical interventions that can even reverse this frequently preventable disorder.
1. Aloia JF, Vaswani A, Yeh JK, Russo L. Differential effects of dietary calcium augmentation and hormone replacement therapy on bone turnover and serum levels of calcitropic hormones. Osteoporos Int 1996;6:55-62.
2. Anonymous. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
. Report of a World Health Organization Study Group. World Heath Organ Tech Rep Ser 1994;843:1-129.
3. Cafabresi E, Lasagni L, Franceschelli F, et al. Comparison of immuno- and HPLC-assays for the measurement of urinary collagen cross-links. J Endocrinol Invest 1994;17:625-9.
4. Courtney AC, Wachtel EF, Myers ER, Hayes WC. Age-related reductions in the strength of the femur tested in a fallloading configuration. J Bone Joint Surg [Am] 1995;77:387-95.
5. Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fracture in white women. N Engl J Med 1995;332:767-3.
6. Cummings SR. Treatable and untreatable risk factors for hip fracture. Bone 1996;18(Suppl):165S-7S.
7. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA 1984;252:1905.
8. Eyre D. Biochemical markers. Spine, 1997;22(Suppl):17S-24S.
9. Felson DT, Zhang Y, Hannan MT, Kannel WB, Kid DP. Alcohol intake and bone mineral density in elderly men and women. The Framingham Study. Am J Epidemiol 1995;142:485-92.
10. Graverand MP, Tron AM, Ichou M, et al. Assessment of urinary hydroxypyridinium cross-links measurement in osteoarthritis. Br J Rheumatol 1996;35:1091-5.
11. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fractures in women. N Engl J Med 1991;324:1326-31.
12. Jackson JA. Osteoporosis
in men. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996:283-8.
13. Johnell O. Advances in osteoporosis
: Better identification of risk factors can reduce morbidity and mortality. J Intern Med 1996;239:299-304.
14. Kaplan FS. Prevention and management of osteoporosis
. CIBA Clin Symp 1995;47:1-32.
15. Kaplan FS, Scherl JD, Wisneski R, Cheatle M, Haddad J. The cluster phenomenon in patients who have multiple vertebral compression fractures. Clin Orthop 1993;297:161-7.
16. Kelepouris N, Harper KD, Gannon F, Kaplan FS, Haddad JG. Severe osteoporosis
in men. Ann Intern Med 1995;123:452-60.
17. Kfeerekoper M, Avioli LV. Evaluation and treatment of postmenopausal osteoporosis
. In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 3rd ed. Philadelphia: Lippincott-Raven Publishers, 1996:264-71.
18. Lindsay R. Osteoporosis
: A Guide to Diagnosis, Prevention and Treatment. National Osteoporosis
Foundation. New York: Raven Press, 1992.
19. Melton III LJ. Epidemiology of fractures. In: Riggs BL, Melton LJ III, eds. Osteoporosis
: Etiology Diagnosis and Management. Philadelphia: Lippincott-Raven Publishers, 1995.
20. Melton III LJ. How many women have osteoporosis
now? J Bone Miner Res 1995;10:175-7.
21. Melton LJ III, Riggs BL. Risk factors for injury after a fall. Clin Geriatr Med 1985;1:525-39.
22. Mosekilde L, Bentzen SM, Ortoft G, Jorgensen J. The predictive value of quantitative computed tomography for vertebral body compressive strength and ash density. Bone 1989;10:465-70.
23. Northridge ME, Nevitt MC, Kelsey JL. Non-syncopal falls in the elderly in relation to home environment. Osteoporos Int 1996;6:249-55.
24. Riggs BL, Melton LJ III. The prevention and treatment of osteoporosis
. N Engl J Med 1992;327:620-7.
25. Riggs BL, Melton LJ III. The worldwide problem of osteoporosis
: Insights afforded by epidemiology. Bone 1995;17(Suppl):505S-11S.
26. Riggs Bl, Wahner HW, Dunn WL, Mazess RB, Offord KP, Melton LJ III. Differential changes in bone mineral density of the appendicular and axial skeleton with aging: Relationship to spinal osteoporosis
. J Clin Invest 1981;67:328-35.
27. Slemenda CW, Hui SL, Loncope C, Wellman H, Johnston CC Jr. Predictors of bone mass in perimenopausal women: A prospective study of clinical data using photon absorptiometry. Ann Intern Med 1990;112:96-101.
28. Spadaro JA, Werner FW, Brenner RA, et al. Cortical and trabecular bone contribute strength to the osteopenic distal radius. J Orthop Res 1994;12:211-8.
29. Thorngren KG. Fractures in the elderly. Acta Orthop Scand 1995;266(Suppl):208-210.
30. Tinetti ME, Bake DI, McAvay G, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994;331:821-7.
31. Tinetti ME, Speechley M. Prevention of falls among the elderly. N Engl J Med 1989;320:1055-9.
Keywords:© Lippincott-Raven Publishers.
osteopenia; osteoporosis; postmenopausal